Gary Mo, Ph.D.

Principal Scientist I

Gary joined Metrum Research Group in 2020. Prior to joining Metrum, he was part of the PK/PD & Pharmacometric department at Eli Lilly and Company where he utilized modeling and simulation to support drug development projects in oncology, neuroscience, and autoimmune. Gary received his Ph.D. from McGill University and completed his postdoctoral training at SUNY University at Buffalo in collaboration with AstraZeneca.